1
TITLE: Effect of zamicastat on blood pressure and heart rate response to cold pressor test: a double-blind, randomised, placebo-controlled study in healthy subjects
AUTHORS: Marlene Fonseca; Cheila Ribeiro; Guillermo Fernández; Helena Gama; Luís Magalhães; Sara Carolina Henriques; Nuno Silva; Filipe Pinto; Luís Almeida; Patricio Soares-da-Silva ;
PUBLISHED: 2023
INDEXED IN: CrossRef
2
TITLE: Absorption, metabolism and excretion of opicapone in human healthy volunteers  Full Text
AUTHORS: Loureiro, Ana, I; Rocha, Francisco; Santos, Ana T.; Singh, Nand; Bonifacio, Maria Joao; Pinto, Rui; Kiss, Laszlo E.; Soares da Silva, Patricio ;
PUBLISHED: 2022, SOURCE: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 88, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 3
3
TITLE: Opicapone as an Add-on to Levodopa in Patients with Parkinson's Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
AUTHORS: Ferreira, Joaquim J.; Poewe, Werner; Rascol, Olivier; Stocchi, Fabrizio; Antonini, Angelo; Moreira, Joana; Pereira, Ana; Rocha, Jose Francisco; Soares da Silva, Patricio ;
PUBLISHED: 2022, SOURCE: NEUROLOGY AND THERAPY, VOLUME: 11, ISSUE: 3
INDEXED IN: WOS
4
TITLE: Opicapone Use in Clinical Practice across Germany: A Sub-Analysis of the OPTIPARK Study in Parkinson's Disease Patients with Motor Fluctuations
AUTHORS: Reichmann, Heinz; Eggert, Karla; Oehlwein, Christian; Warnecke, Tobias; Lees, Andrew J.; Kemmer, Michael; Soares da Silva, Patricio ;
PUBLISHED: 2022, SOURCE: EUROPEAN NEUROLOGY, VOLUME: 85, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 1
5
TITLE: Antagonistic modulation of SIK1 and SIK2 isoforms in high blood pressure and cardiac hypertrophy triggered by high-salt intake  Full Text
AUTHORS: Pires, NM; Igreja, B; Soares da Silva, P ;
PUBLISHED: 2021, SOURCE: CLINICAL AND EXPERIMENTAL HYPERTENSION, VOLUME: 43, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 4
6
TITLE: Complex effects of eslicarbazepine on inhibitory micro networks in chronic experimental epilepsy  Full Text
AUTHORS: Schmidt, S; Pothmann, L; Muller Komorowska, D; Opitz, T; da Silva, PS ; Beck, H;
PUBLISHED: 2021, SOURCE: EPILEPSIA, VOLUME: 62, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 4
7
TITLE: In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy  Full Text
AUTHORS: Monni, L; Kraus, L; Dipper Wawra, M; Soares da Silva, P ; Maier, N; Schmitz, D; Holtkamp, M; Fidzinski, P;
PUBLISHED: 2021, SOURCE: BRITISH JOURNAL OF PHARMACOLOGY, VOLUME: 179, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 6
8
TITLE: Opicapone enhances the reversal of MPTP-induced Parkinson-like syndrome by levodopa in cynomolgus monkeys  Full Text
AUTHORS: Bonifacio, MJ; Sousa, F; Soares da Silva, P ;
PUBLISHED: 2021, SOURCE: EUROPEAN JOURNAL OF PHARMACOLOGY, VOLUME: 892
INDEXED IN: WOS
10
TITLE: Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study (vol 9, 9, 2020)  Full Text
AUTHORS: Reichmann, H; Lees, A; Rocha, JF; Magalhaes, D; Soares da Silva, P ;
PUBLISHED: 2020, SOURCE: TRANSLATIONAL NEURODEGENERATION, VOLUME: 9, ISSUE: 1
INDEXED IN: WOS CrossRef: 34
Page 1 of 75. Total results: 743.